Can brain impermeable BACE1 inhibitors serve as anti-CAA medicine?

Hits:

Release time:2017-08-27
Journal:BMC Neurology
Co-author:Yan XX, Tang BS, Liu F, Huang LL, Li JM
Document Type:R
Volume:17
Issue:1
Page Number:163
Translation or Not:no
Date of Publication:2017-08-25
Links to published journals:https://www.ncbi.nlm.nih.gov/pubmed/28841840

Attachments:

2017-BMC Neurology.pdf

Pre One:Sortilin: a new player in dementia and Alzheimer-type neuropathology

Next One:Early-life lipopolysaccharide exposure potentiates forebrain expression of NLRP3 inflammasome proteins and anxiety-like behavior in adolescent rats

Recommended Ph.D.Supervisor
Recommended MA Supervisor